The prior dichotomous classification of endometrial cancer into high and low risk subtypes based primarily on histology has been shown to be inadequate in predicting outcome and treatment response. More nuanced molecular categorization of these cancers provides improved targeted therapeutic options and a better understanding of the different disease processes.
- Spinosa, D; Montes de Oca, MK; Watson, CH; Berchuck, A; Previs, RA
- January 1, 2022
- Genomic and Precision Medicine: Oncology, Third Edition
Start / End Page
- 191 - 203
International Standard Book Number 13 (ISBN-13)
Digital Object Identifier (DOI)